2016
DOI: 10.5152/turkpediatriars.2016.3836
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the patients diagnosed with Stevens Johnson syndrome and toxic epidermal necrolysis: a single center experience

Abstract: Aim: Stevens Johnson syndrome and toxic epidermal necrolysis are severe acute mucocutaneous diseases. In this study, we evaluated the clinical aspects of Steven Johnson syndrome, toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap patients who admitted to our clinics in the last five years. Material and Methods: Eleven patients diagnosed as Stevens-Johnson syndrome, toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in Department of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…Control spirometry tests, laboratory tests, and psychometric tests were applied. Our group has previously published the acute phase findings, etiological factors, and treatment data of some patients included in our study [8].…”
Section: Patientsmentioning
confidence: 99%
“…Control spirometry tests, laboratory tests, and psychometric tests were applied. Our group has previously published the acute phase findings, etiological factors, and treatment data of some patients included in our study [8].…”
Section: Patientsmentioning
confidence: 99%
“…The majority of the data is extrapolated from small older studies. Some reports suggest that drug-induced SCARs are less prevalent in the pediatric population compared to an adult population (6)(7)(8)(9). A description of the main delayed drug related T-cell mediated hypersensitivity reactions is portrayed in Table 1 with an illustration of the immunopathogenesis and treatment options in Figure 2.…”
Section: Delayed Hypersensitivity Reactionsmentioning
confidence: 99%